BPC157 + TB500 10mg / 20mg

Wolverine stack is the informal nickname for BPC-157 combined with TB-500 — a pairing discussed often enough in research circles to have picked up its own name. This product is exactly that combination, supplied as a single blended vial rather than two separate ones.

It is a single vial containing both BPC-157 and TB-500, supplied as a lyophilised powder. You will see it written BPC 157 TB 500, BPC157 TB500, BPC-157 and TB-500, or simply the Wolverine stack — all describe the same dual-peptide research preparation.

BPC-157 is short for body protection compound 157, and is frequently mistyped as BOC 157, BP 157 or BCP157. TB-500 appears as TB 500, TB500 or TB4, after its parent protein Thymosin Beta-4. All of these refer to the two peptides in this blend.

PhaseOne ships this blend Australia-wide for research use, dispatched locally with tracking, in 10mg and 20mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity for both components.

Yes — PhaseOne has the BPC-157 + TB-500 blend for sale online in 10mg and 20mg vials, shipped Australia-wide. Blends are worth checking carefully, since a single COA should confirm the purity of both peptides rather than just one. Every PhaseOne batch is tested for both components.

PhaseOne prices the blend at A$87.99 for the 10mg vial and A$127.99 for 20mg, with the batch Certificate of Analysis included at no extra cost.

The blend arrives pre-combined in fixed proportions and needs reconstituting once, which suits research designs using both peptides at a set ratio. Separate vials cost more in total but let the ratio be varied independently. (!) View BPC-157 and TB-500 individually.

No. Neither BPC-157 nor TB-500 is registered on the ARTG or approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock either. Both are supplied as research compounds through research suppliers instead.

Researchers across Australia studying recovery and tissue-related pathways often examine BPC-157 and TB-500 together, since each is investigated for a different but complementary mechanism. (!) Read about each individually: BPC-157 and TB-500.

BPC-157 is a regenerative research peptide commonly studied for cellular signalling, gut-related, and tissue-related research pathways within Australian peptide research communities.

TB-500 is studied primarily for actin regulation and cellular migration, derived from the active region of Thymosin Beta-4.

This blend should be stored refrigerated, unreconstituted, and protected from light, in line with standard practice across Australian peptide research. It is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.

Every batch of this blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying both peptide components.

Yes - Australian researchers wanting to add GHK-Cu's copper-binding research profile to this combination can look at our three and four-peptide blends. (!) View our GLOW Blend or KLOW Blend.